GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
3.660
-0.020 (-0.54%)
At close: Aug 10, 2026, 4:00 PM EDT
3.589
-0.071 (-1.93%)
After-hours: Aug 10, 2026, 7:55 PM EDT
GoodRx Holdings Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, GoodRx Holdings stock has a consensus rating of "Hold" and an average price target of $3.86. The average 1-year stock price forecast is 5.46% higher than the current stock price, while the lowest is $2.50 (-31.69%) and the highest is $5.00 (+36.61%).
Price Target: $3.86 (+5.46%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for GoodRx Holdings stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 8 | 8 | 8 | 8 | 8 | 7 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 15 | 15 | 15 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Buy Reiterates $4 → $5 | Buy | Reiterates | $4 → $5 | +36.61% | Aug 10, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $4 → $5 | Buy | Maintains | $4 → $5 | +36.61% | Aug 10, 2026 |
| Raymond James | Raymond James | Buy Maintains $4.5 | Buy | Maintains | $4.5 | +22.95% | Aug 7, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Reiterates $3 → $4 | Hold | Reiterates | $3 → $4 | +9.29% | Aug 7, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Reiterates $3.5 → $4 | Hold | Reiterates | $3.5 → $4 | +9.29% | Aug 7, 2026 |
Financial Forecast
Revenue This Year
795.07M
from 796.85M
Decreased by -0.22%
Revenue Next Year
832.52M
from 795.07M
Increased by 4.71%
EPS This Year
0.31
from 0.35
Decreased by -11.99%
EPS Next Year
0.36
from 0.31
Increased by 16.27%
EPS and Forward PE are based on non-GAAP adjusted numbers.